ArriVent BioPharma Inc. Common Stock (AVBP) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    ArriVent BioPharma Inc. C...

    NASDAQ: AVBP · Real-Time Price · USD
    19.84
    1.01 (5.36%)
    At close: Oct 03, 2025, 3:59 PM
    19.84
    0.00%
    After-hours: Oct 03, 2025, 04:04 PM EDT

    ArriVent BioPharma Common Stock Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -10.42 -9.22 -18.15 -0.49
    PEG Ratio
    		 -0.58 -0.09 0.19 n/a
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 3.25 4.22 3.84 0.62
    P/FCF Ratio
    		 -11.94 -11.45 -15.35 -2.03
    P/OCF Ratio
    		 -11.94 -11.45 -15.35 -2.03
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 0.00 0.00 0.00 n/a
    Quick Ratio
    		 13.14 13.76 21.84 23.63
    Current Ratio
    		 13.14 13.76 21.84 23.63
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 n/a n/a n/a n/a
    Return on Equity
    		 -0.31 -0.46 -0.21 -1.25
    Return on Assets
    		 -0.29 -0.43 -0.2 -1.2
    Return on Invested Capital
    		 -0.37 -0.49 -0.21 -0.16
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist